SCHEMBL7369022

SCHEMBL7369022

CNC(=O)C(=O)CCCCCCC(=O)Nc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.80

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 12/20 0.80
HDAC2 Q92769 12/20 0.80
HDAC3 O15379 7/20 0.78
HDAC4 P56524 7/20 0.78
HDAC7 Q8WUI4 7/20 0.78
HDAC10 Q969S8 7/20 0.78
HDAC11 Q96DB2 7/20 0.78
HDAC8 Q9BY41 7/20 0.78
HDAC6 Q9UBN7 7/20 0.78
HDAC9 Q9UKV0 7/20 0.78
HDAC5 Q9UQL6 7/20 0.78
RNF4 P78317 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
LTA4H P09960 3/20 0.53
POLB P06746 1/20 0.53
MTNR1A P48039 1/20 0.53
MTNR1B P49286 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2704165 0.88 HDAC1 (1.00) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL9240178 0.86 HDAC1 (0.83) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7373364 0.85 HDAC1 (0.60) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL5662196 0.83 HDAC1 (0.69) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL5319266 0.82 HDAC3 (0.72) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL3228056 0.81 HDAC1 (0.76) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL5661162 0.79 LTA4H (0.73) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL2171203 0.79 HDAC1 (0.71) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL17194390 0.78 HDAC1 (0.70) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7373722 0.78 HDAC1 (1.00) HDAC1HDAC2HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US claimed
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103192-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC4 HDAC1 1/4885HDAC2 7/4885HDAC3 6/4885
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 HDAC1 1/4885HDAC2 4/4885HDAC3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.